WO2007041276A3 - Methodes permettant de moduler l'apoptose, la croissance cellulaire et l'expression des proteines au moyen de compositions a base de plantes - Google Patents
Methodes permettant de moduler l'apoptose, la croissance cellulaire et l'expression des proteines au moyen de compositions a base de plantes Download PDFInfo
- Publication number
- WO2007041276A3 WO2007041276A3 PCT/US2006/038019 US2006038019W WO2007041276A3 WO 2007041276 A3 WO2007041276 A3 WO 2007041276A3 US 2006038019 W US2006038019 W US 2006038019W WO 2007041276 A3 WO2007041276 A3 WO 2007041276A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- protein expression
- cellgrowth
- modulating apoptosis
- herbal compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des méthodes permettant de moduler l'apoptose, la croissance cellulaire et l'expression des protéines, laquelle méthode consiste à administrer des quantités thérapeutiquement efficaces d'extraits supercritiques de romarin, de curcuma, d'origan et de gingembre; et des quantités thérapeutiquement efficaces d'extraits hydro-alcooliques d'ocimum sanctus, de gingembre, de curcuma, de Scutellaria baicalensis, de romarin, de thé vert, de huzhang, de coptide chinois, et d'épine vinette.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72158305P | 2005-09-29 | 2005-09-29 | |
US60/721,583 | 2005-09-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007041276A2 WO2007041276A2 (fr) | 2007-04-12 |
WO2007041276A3 true WO2007041276A3 (fr) | 2007-11-22 |
Family
ID=37906729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/038019 WO2007041276A2 (fr) | 2005-09-29 | 2006-09-29 | Methodes permettant de moduler l'apoptose, la croissance cellulaire et l'expression des proteines au moyen de compositions a base de plantes |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007041276A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7158285B2 (ja) | 2016-05-23 | 2022-10-21 | イエール ユニバーシティ | Phy906抽出物、スクテラリア・バイカレンシス・ジョージ(s)抽出物、またはそのような抽出物に由来する化合物を含む併用療法を用いることによる、抗免疫チェックポイント阻害剤の治療指数の改善方法 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2015309351B2 (en) * | 2014-08-28 | 2019-01-03 | Caliway Biopharmaceuticals Co., Ltd. | Composition and medicinal product for reducing body weight and body fat, and use of said product |
MX2017002585A (es) | 2014-08-28 | 2017-05-25 | Caliway Biopharmaceuticals Co Ltd | Composicion para reducir la grasa local y el peso corporal y sustancias farmaceuticas y uso de las mismas. |
US10226503B2 (en) | 2014-08-28 | 2019-03-12 | Caliway Biopharmaceuticals Co., Ltd. | Plant extract composition for reducing topical fat and promoting weight loss as well as applications thereof |
US10537548B2 (en) | 2014-08-28 | 2020-01-21 | Caliway Biopharmaceuticals Co., Ltd. | Composition and medical product for reducing body weight and body fat, and use of said product |
CA2995158C (fr) | 2015-08-28 | 2021-05-11 | Caliway Biopharmaceuticals Co., Ltd. | Une composition pharmaceutique destinee a reduire les graisses locales, et ses utilisations |
US11318110B2 (en) | 2015-08-28 | 2022-05-03 | Caliway Biopharmaceuticals Co., Ltd. | Pharmaceutical composition for reducing local fat and uses thereof |
CN110585443A (zh) * | 2019-09-04 | 2019-12-20 | 中国人民解放军陆军军医大学第一附属医院 | 一种抑制胶质瘤侵袭性生长的复合物及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050123631A1 (en) * | 2003-12-05 | 2005-06-09 | Thomas Newmark | Methods for treating prostate cancer with herbal compositions |
-
2006
- 2006-09-29 WO PCT/US2006/038019 patent/WO2007041276A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050123631A1 (en) * | 2003-12-05 | 2005-06-09 | Thomas Newmark | Methods for treating prostate cancer with herbal compositions |
Non-Patent Citations (2)
Title |
---|
AALTOMAA S. ET AL.: "Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer", THE PROSTATE, vol. 39, no. 1, March 1999 (1999-03-01), pages 8 - 15, XP002213568 * |
NARAYANAN ET AL.: "Diffrential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets", INTERNATIONAL JOURNAL OF CANCER, vol. 104, no. 2, January 2003 (2003-01-01), pages 204 - 212, XP008091541 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7158285B2 (ja) | 2016-05-23 | 2022-10-21 | イエール ユニバーシティ | Phy906抽出物、スクテラリア・バイカレンシス・ジョージ(s)抽出物、またはそのような抽出物に由来する化合物を含む併用療法を用いることによる、抗免疫チェックポイント阻害剤の治療指数の改善方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2007041276A2 (fr) | 2007-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1706125A4 (fr) | Procedes pour le traitement de la neoplasie localisee prostatique avec des compositions a base de plantes medicinales | |
WO2007041276A3 (fr) | Methodes permettant de moduler l'apoptose, la croissance cellulaire et l'expression des proteines au moyen de compositions a base de plantes | |
ATE406168T1 (de) | Entzündungshemmendes kräuterpräparat | |
WO2009080778A3 (fr) | Préparation avec des extraits de cynorhodon, et procédé de fabrication d'extraits de cynorhodon | |
WO2005091953A3 (fr) | Compositions d'extraits de feuilles de morinda citrifolia et procedes de preparation associes | |
SG161214A1 (en) | A pharmaceutical composition for treating depression and method for preparation thereof | |
MY148739A (en) | Pharmaceutical composition containing ephedrae herba for treating bronchitis and preparation method thereof | |
WO2010034971A3 (fr) | Extraction dans l’eau sous-critique de plantes médicinales | |
WO2006026284A3 (fr) | Compositions phytopharmaceutiques pour prevenir et/ou traiter des maladies cardio-vasculaires et procede pour les preparer | |
PH12019501512A1 (en) | Use of at least one glycyrrhiza plant-based preparation, an antidote made from same, and the use of said antidote | |
WO2010086717A3 (fr) | Compositions nettoyantes à base de plantes et leur procédés de préparation | |
WO2011083398A3 (fr) | Composition phytothérapeutique pour la diarrhée | |
WO2011105839A3 (fr) | Composition de peau externe et son procédé de production | |
WO2008149437A1 (fr) | Nutrition capillaire orale pour le traitement de l'alopécie en plaques multiples | |
CN104056148A (zh) | 一种能够解酒的中药组合物 | |
WO2012123962A3 (fr) | Nouvelle composition à base de plantes médicinales pour le traitement d'une cicatrisation de plaie, médecine régénérative | |
CN104286267A (zh) | 一种驱寒茶 | |
WO2005049058A8 (fr) | Radix salviae miltiorrhizae, extrait et composition destines au traitement des maladies de resistance a l'aspirine | |
Cui et al. | Studies on the active constituents in vine stem of Spatholobus suberectus | |
EP1900372A8 (fr) | Composition pour augmenter la fertilité masculine | |
CN103229998A (zh) | 一种具有解酒护肝作用的制剂及制备方法 | |
Furrianca et al. | Phytochemical constituents of the root of Berberis microphylla | |
CN105192008A (zh) | 一种月季红蜘蛛病害的防治用药及其制备方法 | |
梅文莉 et al. | Bioactive Constituents from Hydnocarpus hainanensis (Merr.) Sleum. | |
WO2014008901A2 (fr) | Utilisation de l'artichaut pour l'éradication du virus de l'hépatite c (vhc) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06815765 Country of ref document: EP Kind code of ref document: A2 |